Pain at Work Toolkit in Employees With Chronic Pain
PAW
Multicentre Pragmatic Cluster Randomised Controlled Feasibility Trial to Assess Potential Effectiveness and Cost-effectiveness of the Pain at Work Toolkit in Employees With Chronic or Persistent Pain
3 other identifiers
interventional
380
1 country
1
Brief Summary
This project will test the feasibility and acceptability of the Pain at Work (PAW) Toolkit which aims to help employees self-manage chronic or persistent pain at work. Ultimately, the investigators want to discover if it improves employees' health, wellbeing, confidence to self-manage their condition, and reduces impacts on their ability to work and be productive at work. Prior to testing the effectiveness and cost-effectiveness of the PAW Toolkit in a large-scale randomised trial, the investigators are conducting a multicentre pragmatic cluster randomised controlled feasibility trial. This will establish whether the PAW Toolkit, and our research processes, are feasible and acceptable in workplace settings, and will inform the design of a future trial. In this feasibility study, organisations will be randomised at site level to receive the intervention (PAW Toolkit plus occupational therapist (OT) support calls) or control (treatment as usual) for any individual employees who consent to take part. The investigators aim to recruit around 120 participants ("individual employees") from around 8 sites ("clusters"). Data will be collected from employees and organisations at baseline, 3 months and 6 months, using online surveys. At 6 months, up tp 40 people from across different sites and job roles will be interviewed, including employees who have accessed the PAW Toolkit, and other stakeholders (people who have been involved in supporting them at work, such as their line manager). The data will be used assess whether the intervention and the research processes are acceptable and feasible, and the information collected will be used to plan a large-scale randomised controlled trial.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-pain
Started Jul 2023
Typical duration for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2023
CompletedFirst Posted
Study publicly available on registry
May 1, 2023
CompletedStudy Start
First participant enrolled
July 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 22, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2025
CompletedDecember 18, 2025
November 1, 2023
2.1 years
March 27, 2023
December 11, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
Recruitment to the study
Number recruited to assess whether it would be possible to recruit to a definitive trial. The investigators will record the number recruited, characteristics of those recruited, and the timescale to recruit.
Baseline
Acceptability of Intervention
Outcome to assess whether participants find the intervention acceptable. This will be self-reported in participant interviews at 6 months.
6 months
Fidelity of intervention (PAW Toolkit)
Intervention fidelity will be checked through collection of usage data for the PAW Toolkit, to assess engagement with the intervention. This data will be collected through a feedback form at 3 months.
3 months
Fidelity of intervention (OT support calls)
Intervention fidelity will be checked through recording of the uptake of occupational therapy support calls (to assess engagement with the intervention). This data will be collected through forms completed by the therapist at the time of each phone call which will be summed at 3 months.
3 months
Retention to the study at 3 months
Number of participants who complete the first follow-up outcome measures survey.
3 months
Retention to the study at 6 months
Number of participants who complete the second follow-up outcome measures survey.
6 months
Secondary Outcomes (12)
Work presenteeism
To assess change between time 0 (baseline), time 1 (3 months) and time 2 (6 months).
Work Ability
To assess change between time 0 (baseline), time 1 (3 months) and time 2 (6 months).
Work Self-Efficacy
To assess change between time 0 (baseline), time 1 (3 months) and time 2 (6 months).
Job satisfaction
To assess change between time 0 (baseline), time 1 (3 months) and time 2 (6 months).
Job stressfulness
To assess change between time 0 (baseline), time 1 (3 months) and time 2 (6 months).
- +7 more secondary outcomes
Other Outcomes (3)
Organisation-reported sickness absence records
To assess change between time 0 (baseline), time 1 (3 months) and time 2 (6 months).
Employment status
To document any changes in participant's employment status between time 0 (baseline), time 1 (3 months) and time 2 (6 months).
Nature of work
To document any changes in participant's nature of work between time 0 (baseline), time 1 (3 months) and time 2 (6 months).
Study Arms (2)
Intervention Group: Pain at Work Toolkit
EXPERIMENTALIntervention participants receive the PAW toolkit plus 3 x optional occupational therapy calls (approximately 30 minutes each) involving orientation to the PAW Toolkit and individually tailored advice and behavioural strategies for managing pain at work. This digital web-based toolkit is designed to support people with chronic pain in self-managing their condition at work. PAW offers evidence-based advice about chronic or persistent pain, disability rights, work capacity, pain self-management strategies and signposting to support.
Active Control Group: Treatment as Usual
ACTIVE COMPARATORParticipants do not receive the PAW Toolkit but instead have treatment as usual (TAU) from their employer. The nature of TAU will be recorded as part of the feasibility study. Depending on the employing organisation, TAU may consist of (but is not limited to) any combination of the following: occupational health, counselling, line manager support, signposting to education about factors that may have positive or negative effects on chronic pain. Participants can access non-specialist telephone calls from a researcher to discuss their participation in the study.
Interventions
Treatment as usual which will vary depending on the employing organisation but may include, for example, line manager support, occupational health input etc. Access to optional non-specialist phone call support from a study researcher.
Online toolkit providing advice and signposting to help people self-manage chronic or persistent pain at work. Access to optional phone call support from an occupational therapist providing individually tailored advice.
Eligibility Criteria
You may qualify if:
- organisations in England
- organisations with 10 or more employees.
- working-age adults (employees)
- aged 18 and over
- self-reported chronic pain interfering with their ability to undertake or enjoy productive work
- able to comprehend English language
- able to provide informed consent.
- access to the internet to be able to access the web-based intervention and online surveys for data collection.
You may not qualify if:
- organisations outside of England
- micro-organisations with fewer than 10 employees
- unemployed at recruitment
- under 18 years of age
- no chronic pain at recruitment
- unable to comprehend English language
- unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Exetercollaborator
- Monash Universitycollaborator
- Versus Arthritiscollaborator
- Nuffield Trustcollaborator
- University of Aberdeencollaborator
- University of Nottinghamlead
Study Sites (1)
University of Nottingham
Nottingham, NG7 2HA, United Kingdom
Related Publications (3)
Blake H, Somerset S, Greaves S. The Pain at Work Toolkit for Employees with Chronic or Persistent Pain: A Collaborative-Participatory Study. Healthcare (Basel). 2021 Dec 29;10(1):56. doi: 10.3390/healthcare10010056.
PMID: 35052220BACKGROUNDBlake H, Chaplin WJ, Wainwright E, Taylor G, McNamee P, McWilliams D, Abbott-Fleming V, Holmes J, Fecowycz A, Walsh DA, Walker-Bone K. The Web-Based Pain-at-Work Toolkit With Telephone Support for Employees With Chronic or Persistent Pain: Protocol for a Cluster Randomized Feasibility Trial. JMIR Res Protoc. 2023 Oct 30;12:e51474. doi: 10.2196/51474.
PMID: 37902814BACKGROUNDBlake H, Abbott-Fleming V, Greaves S, Somerset S, Chaplin WJ, Wainwright E, Walker-Bone K. Five years of patient and public involvement and engagement (PPIE) in the development and evaluation of the Pain-at-Work toolkit to support employees' self-management of chronic pain at work. Res Involv Engagem. 2025 Jul 15;11(1):81. doi: 10.1186/s40900-025-00757-5.
PMID: 40665420DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Holly Blake, PhD
University of Nottingham
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2023
First Posted
May 1, 2023
Study Start
July 1, 2023
Primary Completion
July 22, 2025
Study Completion
November 30, 2025
Last Updated
December 18, 2025
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Protocol - baseline (registration) 6 months (submitted protocol for publication) Statistical analysis plan - baseline Informed consent form - 6 months (submitted protocol for publication)
- Access Criteria
- Protocol - details shared via clinical trials.gov and protocol manuscript (with informed consent form) to be submitted to an open access peer-reviewed journal within 6 months. Data Management Plan will be publicly available on https://dmponline.dcc.ac.uk prior to ethical approval and study start.
Protocol - details shared via clinical trials.gov and protocol manuscript (with informed consent form) to be submitted to an open access peer-reviewed journal within 6 months. Data Management Plan will be publicly available on https://dmponline.dcc.ac.uk prior to study start.